These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 33523735)

  • 1. Institutions For Mental Diseases Medicaid Waivers: Impact On Payments For Substance Use Treatment Facilities.
    Maclean JC; Wen H; Simon KI; Saloner B
    Health Aff (Millwood); 2021 Feb; 40(2):326-333. PubMed ID: 33523735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in Medicaid Acceptance by Substance Abuse Treatment Facilities After Implementation of Federal Parity.
    Geissler KH; Evans EA
    Med Care; 2020 Feb; 58(2):101-107. PubMed ID: 31688556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Housing Is Mental Health Care: A Call for Medicaid Demonstration Waivers Covering Housing.
    Mathis J
    Psychiatr Serv; 2021 Aug; 72(8):880-884. PubMed ID: 33334151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Residential treatment and medication treatment for opioid use disorder: The role of state Medicaid innovations in advancing the field.
    O'Brien PL; Stewart MT; Shields MC; White M; Dubenitz J; Dey J; Mulvaney-Day N
    Drug Alcohol Depend Rep; 2022 Sep; 4():. PubMed ID: 36157615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in Availability and Use of Medications for Opioid Use Disorder in Residential Treatment Settings in the United States.
    Huhn AS; Hobelmann JG; Strickland JC; Oyler GA; Bergeria CL; Umbricht A; Dunn KE
    JAMA Netw Open; 2020 Feb; 3(2):e1920843. PubMed ID: 32031650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating the role of Section 1115 waivers on Medicaid coverage and utilization of opioid agonist therapy among substance use treatment admissions.
    Tormohlen KN; Krawczyk N; Feder KA; Riehm KE; Crum RM; Mojtabai R
    Health Serv Res; 2020 Apr; 55(2):232-238. PubMed ID: 31884703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generosity and Duration of Medicaid Expansion Waivers and Access to Care.
    Tarazi WW; Bradley CJ; Harless DW; Bear HD; Sabik LM
    Am J Prev Med; 2018 Nov; 55(5):624-632. PubMed ID: 30224224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Race/ethnicity and geographic access to Medicaid substance use disorder treatment facilities in the United States.
    Cummings JR; Wen H; Ko M; Druss BG
    JAMA Psychiatry; 2014 Feb; 71(2):190-6. PubMed ID: 24369387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effect of the Drug Medi-Cal Organized Delivery System 1115 Demonstration Waiver on Substance Use Disorder Treatment Access: Evidence from California.
    Bass B; Urada D; Khurana D; Boustead A; Joshi V
    Drug Alcohol Depend; 2023 May; 246():109847. PubMed ID: 37001321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship of Medicaid expansion to psychiatric comorbidity care within substance use disorder treatment programs.
    Shover CL; Abraham A; D'Aunno T; Friedmann PD; Humphreys K
    J Subst Abuse Treat; 2019 Oct; 105():44-50. PubMed ID: 31443890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How Do Medicaid Agencies Improve Substance Use Treatment Benefits? Lessons from Three States' 1115 Waiver Experiences.
    Crable E; Jones DK; Walley AY; Hicks JM; Benintendi A; Drainoni ML
    J Health Polit Policy Law; 2022 Aug; 47(4):497-518. PubMed ID: 35044466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Achieving Access Parity for Inpatient Psychiatric Care Requires Repealing the Medicaid Institutions for Mental Disease Exclusion Rule.
    DuBose BM; Fry-Bowers EK
    Policy Polit Nurs Pract; 2021 Feb; 22(1):63-72. PubMed ID: 33131405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Medicaid expansion and 1115 waivers for substance use disorders with hospital provision of opioid use disorder services: a cross sectional study.
    Chang JE; Cronin CE; Lindenfeld Z; Pagán JA; Franz B
    BMC Health Serv Res; 2023 Jan; 23(1):87. PubMed ID: 36703146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reducing Behavioral Health Inpatient Readmissions for People With Substance Use Disorders: Do Follow-Up Services Matter?
    Reif S; Acevedo A; Garnick DW; Fullerton CA
    Psychiatr Serv; 2017 Aug; 68(8):810-818. PubMed ID: 28412900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in Residential Substance Use Treatment Service Access Resulting From Recent Medicaid Section 1115 Waivers.
    Miles J
    Psychiatr Serv; 2019 May; 70(5):428-431. PubMed ID: 30755128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lagging coverage for mental health services among children and adolescents through home and community-based Medicaid waivers.
    Keim-Malpass J; Constantoulakis L; Shaw EK; Letzkus LC
    J Child Adolesc Psychiatr Nurs; 2023 Feb; 36(1):21-27. PubMed ID: 36075862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translating Medicaid policy into practice: policy implementation strategies from three US states' experiences enhancing substance use disorder treatment.
    Crable EL; Benintendi A; Jones DK; Walley AY; Hicks JM; Drainoni ML
    Implement Sci; 2022 Jan; 17(1):3. PubMed ID: 34991638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. State parity laws and access to treatment for substance use disorder in the United States: implications for federal parity legislation.
    Wen H; Cummings JR; Hockenberry JM; Gaydos LM; Druss BG
    JAMA Psychiatry; 2013 Dec; 70(12):1355-62. PubMed ID: 24154931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insurance barriers to substance use disorder treatment after passage of mental health and addiction parity laws and the affordable care act: A qualitative analysis.
    Dickson-Gomez J; Weeks M; Green D; Boutouis S; Galletly C; Christenson E
    Drug Alcohol Depend Rep; 2022 Jun; 3():100051. PubMed ID: 36845978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medicaid 1915(c) Home- and Community-Based Services waivers for children with autism spectrum disorder.
    Velott DL; Agbese E; Mandell D; Stein BD; Dick AW; Yu H; Leslie DL
    Autism; 2016 May; 20(4):473-82. PubMed ID: 26088059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.